https://www.selleckchem.com/pr....oducts/levofloxacin-
Conversely, mice lacking SLC6A20A displayed increased extracellular glycine levels and NMDAR currents. Lastly, both mouse and human SLC6A20 proteins mediated proline and glycine transports, and SLC6A20 proteins could be detected in human neurons. These results suggest that SLC6A20 regulates proline and glycine homeostasis in the brain and that SLC6A20 inhibition has therapeutic potential for brain disorders involving NMDAR hypofunction.Regorafenib is approved for patients with unresectable hepatocellular carcinoma (HC
Aimer
Commentaire
Partagez
